In reaction to chemotherapy-induced DNA damage, reactive oxygen species (ROS) induces UBE2F-mediated neddylation of CUL5, facilitating NOXA ubiquitination and degradation, which confers chemoresistance to CRC cells [36]. The gene discussed is UBE2F; the disease is colorectal carcinoma.